ID
45518
Descrizione
Principal Investigator: Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA MeSH: Waldenstrom Macroglobulinemia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000740 Whole genome sequencing was conducted on 10 tumor/germline paired samples along with 20 additional unpaired tumor samples from patients with Waldesntrom's macroglobulinemia. Tumor lymphoplasmacytic lymphoma cells were obtained from CD19+ selected bone marrow mononuclear cells. Germline tissue was obtained from CD19 depleted peripheral blood mononuclear cells. High molecular weight DNA was then submitted for whole genome sequencing with Complete Genomics and aligned to HG19/NCBI human reference build 37.
collegamento
Keywords
versioni (1)
- 14/12/22 14/12/22 - Chiara Middel
Titolare del copyright
Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, USA
Caricato su
14 dicembre 2022
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs000740 Whole Genome Sequencing of Waldenstrom's Macroglobulinemia
Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, and sequencing center variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sex, and paired germ line sample control of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
Similar models
Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, subject source, source subject ID, and affection status of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sample ID, sample source, sample source ID, and sample use variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Sample ID, body site where sample was obtained, analyte type, tumor status of sample, histological type of sample, and sequencing center variable associated with participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
- Subject ID, sex, and paired germ line sample control of participants with or without Waldesntrom macroglobulinemia and involved in the "Whole Genome Sequencing of Waldenstrom's Macroblulinemia".
C0441833 (UMLS CUI [1,2])
C0242481 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
C3847505 (UMLS CUI [1,2])
C0449416 (UMLS CUI [1,3])